Evidence map›Paper›PMID 30191362›Full record

ArticleEuropean journal of epidemiology2018

A population based pediatric oncology registry in Southern Sweden: the BORISS registry.

Thomas Wiebe, Lars Hjorth, Mercedes Marotta Kelly, Helena M Linge, Stanislaw Garwicz

Open access · hybridAbstract read
In one paragraph

Article in European journal of epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thomas WiebeFaculty of Medicine, Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden.
Lars HjorthFaculty of Medicine, Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden.
Mercedes Marotta KellyRegional Cancer Center South, Lund, Sweden.
Helena M LingeFaculty of Medicine, Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden. helena.linge@med.lu.se.
Stanislaw GarwiczFaculty of Medicine, Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden.
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A population based registry, with the acronym BORISS, was established. It contains all individuals (0-18 years of age at diagnosis) diagnosed with cancer from 1970-01-01 until 2016-12-31 in Southern Sweden. The treatment data has been entered into the registry after confirmation of the diagnosis by the Swedish national cancer registry and updates on vital status from the Swedish population registry. The number of individuals with a pediatric cancer diagnosed during these 46 years are 2928. Of these, 2065 are currently alive and 1882 individuals are 5-year survivors. Data on treatment and malignancy of the 5-year survivors has been collected from medical records and entered into the database. Treatment data contains surgical procedure, target organ of radiation therapy including dose and fractionation, and cytostatic treatment with dose (mg) per body surface area (m

Indexed as

AdolescentChildChild, PreschoolDatabases, FactualFemaleHumansInfantInfant, NewbornMaleNeoplasmsPopulation SurveillanceRegistriesSurvivorsSwedenChildhood cancer survivorshipPopulation basedRegistrySweden

Identifiers

PMID30191362
PMCPMC6208984
OpenAlexW2889899350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.